MaxCyte outlines $17M–$19M annualized savings through restructuring while reiterating SPL revenue guidance [Seeking Alpha]
MaxCyte, Inc. (MXCT)
Company Research
Source: Seeking Alpha
CEO Maher Masoud reported $6.8 million in total revenue for the third quarter, including $6.4 million in core revenue and $0.4 million in SPL program-related revenue, noting the quarter was "a bit light due to timing of Quick Insights MaxCyte is implementing a major restructuring, reducing workforce by 34%, targeting $17-19 million in annualized savings, and maintaining guidance while adapting its cost structure to market conditions. Management remains confident in signing 3-5 SPLs per year, sees a broader SPL funnel, and anticipates pivotal trial progress and future commercial launches, supporting long-term growth despite headwinds. The company expects stable cash reserves ($152-155 million at 2025 end), controlled cash burn, strong gross margins, and cost discipline through restructuring, supporting operational and financial stability. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
MXCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MXCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MXCT alerts
High impacting MaxCyte, Inc. news events
Weekly update
A roundup of the hottest topics
MXCT
News
- MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- MaxCyte (NASDAQ:MXCT) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MXCT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> MarketBeat
- Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO [Yahoo! Finance]Yahoo! Finance
- Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPOBusiness Wire
MXCT
Earnings
- 11/12/25 - Miss
MXCT
Sec Filings
- 2/5/26 - Form SCHEDULE
- 1/21/26 - Form SCHEDULE
- 1/12/26 - Form 8-K
- MXCT's page on the SEC website